NEORAL
NOVARTIS PHARMACEUTICALS CANADA INC
Quick answers
Is there a shortage of NEORAL in Canada?
No. There is no current shortage of NEORAL 100MG reported to Health Canada. Stock can still vary from one pharmacy to another.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
Other Products
NEORAL
NOVARTIS PHARMACEUTICALS CANADA INC
SANDIMMUNE I.V.
NOVARTIS PHARMACEUTICALS CANADA INC
CEQUA
SUN PHARMACEUTICAL INDUSTRIES LIMITED
RESTASIS
ABBVIE CORPORATION
RESTASIS MULTIDOSE
ABBVIE CORPORATION
VERKAZIA
APOTEX INC
DIN
02150697
Strength
100MG
Dosage Form
Solution
Route
Oral
Compare with another product →
Shortage History
No shortage or discontinuation reports on file for this product.
Other Products from NOVARTIS PHARMACEUTICALS CANADA INC
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
10MG · DIN 02339528
5MG · DIN 02339501
2.5MG · DIN 02369257
7.5MG · DIN 02450267
5MG · DIN 02425661
3MG · DIN 02425653
2MG · DIN 02425645
70MG · DIN 02479613
140MG · DIN 02487306
0.1% · DIN 00893560
100MG · DIN 02381559
1000MG · DIN 02381567